GLX351322
CAS No. 835598-94-2
GLX351322( —— )
Catalog No. M21200 CAS No. 835598-94-2
GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 126 | In Stock |
|
| 2MG | 40 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 106 | In Stock |
|
| 25MG | 242 | In Stock |
|
| 50MG | 405 | In Stock |
|
| 100MG | 602 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGLX351322
-
NoteResearch use only, not for human use.
-
Brief DescriptionGLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.
-
DescriptionGLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.
-
In VitroGLX351322 is an inhibitor of NADPH oxidase 4, and inhibits hydrogen peroxide production from NOX4-overexpressing cells with an IC50 of 5 μM. GLX351322 shows weak activity against NOX2 in hPBMC cells (IC50, 40 μM).
-
In VivoGLX351322 (3.8 mg/kg/day, p.o.) ameliorates HFD-induced hyperglycemia in mice.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNADPH
-
RecptorNOX4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number835598-94-2
-
Formula Weight431.5
-
Molecular FormulaC21H25N3O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:20 mg/mL (46.35 mM; Need ultrasonic)
-
SMILESCCOC(=O)c1c(NC(=O)CN2CCN(C(=O)c3ccco3)CC2)sc2c1CCC2
-
Chemical NameEthyl 2-[[2-[4-(furan-2-carbonyl)piperazin-1-yl]acetyl]amino]-56-dihydro-4H-cyclopenta-[b]thiophene-3-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Anvari Ebrahim Wikstr?m Per Walum Eriket al. The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice[J]. Free Radical Research 49(11):1-32.
molnova catalog
related products
-
AKR1C3-IN-4
AKR1C3-IN-4 is a potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC 50 of 0.56 μM. AKR1C3-IN-4 has the potential for castrate resistant prostate cancer (CRPC) research.
-
S29434
S29434 (NMDPEF) is a potent competitiveinhibitor of quinone reductase 2 (QR2;IC50:5-16nM).
-
GKT137831
GKT137831 (Setanaxib, GKT-137831) is a potent, selective, dual NADPH oxidase Nox1/4 inhibitor with Ki of 110/140 nM.
Cart
sales@molnova.com